Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8,255 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Casein kinase 1 inhibitor avoids TDP-43 pathology propagation in a patient-derived cellular model of amyotrophic lateral sclerosis.
Cuevas EP, Martinez-Gonzalez L, Gordillo C, Tosat-Bitrián C, Pérez de la Lastra C, Sáenz A, Gil C, Palomo V, Martin-Requero Á, Martinez A. Cuevas EP, et al. Among authors: martinez gonzalez l, martinez a. Neurobiol Dis. 2024 Mar;192:106430. doi: 10.1016/j.nbd.2024.106430. Epub 2024 Feb 5. Neurobiol Dis. 2024. PMID: 38325718 Free article.
Prenylated Flavanone Isolated from Dalea Species as a Potential Multitarget-Neuroprotector in an In Vitro Alzheimer's Disease Mice Model.
Santi MD, Carvalho D, Dapueto R, Bentura M, Zeni M, Martínez-González L, Martínez A, Peralta MA, Rey A, Giglio J, Ortega MG, Savio E, Abin-Carriquiry JA, Arredondo F. Santi MD, et al. Among authors: martinez gonzalez l, martinez a. Neurotox Res. 2024 Apr 5;42(2):23. doi: 10.1007/s12640-024-00703-5. Neurotox Res. 2024. PMID: 38578482
MBC and ECBL libraries: outstanding tools for drug discovery.
Ginex T, Madruga E, Martinez A, Gil C. Ginex T, et al. Among authors: martinez a. Front Pharmacol. 2023 Aug 11;14:1244317. doi: 10.3389/fphar.2023.1244317. eCollection 2023. Front Pharmacol. 2023. PMID: 37637414 Free PMC article.
Rapid discovery and crystallography study of highly potent and selective butylcholinesterase inhibitors based on oxime-containing libraries and conformational restriction strategies.
Jing L, Wei W, Meng B, Chantegreil F, Nachon F, Martínez A, Wu G, Zhao H, Song Y, Kang D, Brazzolotto X, Zhan P, Liu X. Jing L, et al. Among authors: martinez a. Bioorg Chem. 2023 May;134:106465. doi: 10.1016/j.bioorg.2023.106465. Epub 2023 Mar 11. Bioorg Chem. 2023. PMID: 36933339
Selection of disease modifying therapies in multiple sclerosis based on patient's age and disease activity: Data from a nationwide registry.
Piedrabuena MA, Correale J, Fiol M, Marrodan M, Rojas JI, Alonso M, Pappolla A, Miguez J, Patrucco L, Cristiano E, Vrech C, Cohen L, Alonso R, Silva B, Luetic G, Deri N, Burgos M, Liwacki S, Piedrabuena R, Tkachuk V, Barboza A, Martinez A, Balbuena ME, Pinheiro AA, Nofal P, Lopez PA, Tavolini D, Leguizamon F, Hryb JP, Tizio S, Recchia L, Reich E, Contentti EC, Marcilla MP, Pagani F, Cabrera LM, Curbelo MC, Mainella C, Liguori NF, Coppola M, Pettinicchi JP, Carra A, Jose G, Nadur D, Bestoso S, Pestchanker C, Vazquez GD, Martinez CM, Ysrraelit MC. Piedrabuena MA, et al. Among authors: martinez a. J Neurol Sci. 2024 May 16;461:123052. doi: 10.1016/j.jns.2024.123052. Online ahead of print. J Neurol Sci. 2024. PMID: 38797140
8,255 results